Related Experiment Videos
Statin dose in Asians: is pharmacogenetics relevant?
1Department of Pathology & Laboratory Medicine, The Methodist Hospital & The Methodist Hospital Research Institute, Houston, TX 77030, USA. pwang@tmhs.org
Pharmacogenomics
|November 3, 2011
Summary
Asian and Caucasian populations show differences in statin efficacy and safety. This review examines whether lower statin doses are needed for Asians, considering body weight, BMI, and pharmacogenetics.
Area of Science:
- Pharmacology
- Genetics
- Cardiovascular Medicine
Background:
- Statin efficacy and safety research has historically focused on Western populations.
- Recent studies highlight similarities and differences in statin use between Asian and Caucasian individuals.
Purpose of the Study:
- To critically review the literature on whether Asians require lower statin doses than Caucasians.
- To investigate the scientific evidence behind perceived dose differences, considering body weight, BMI, and pharmacogenetics.
- To summarize current knowledge and outline future research directions in statin therapy for diverse populations.
Main Methods:
- Comprehensive literature review of studies comparing statin efficacy and safety in Asian and Caucasian populations.
- Analysis of factors influencing statin dosing, including body weight, body mass index (BMI), and genetic variations (pharmacogenetics).
Main Results:
- Evidence suggests potential differences in statin response between Asian and Caucasian individuals.
- Pharmacogenetic factors may play a role in determining optimal statin dosage, influencing both efficacy and safety.
- The common belief of lower statin doses for Asians due to lower body weight requires scientific validation.
Conclusions:
- There is a clinical need to establish evidence-based statin dosing guidelines tailored to different ethnic groups.
- Further research into pharmacogenetics is crucial for personalized statin therapy.
- Understanding ethnic variations in statin response can optimize cardiovascular disease prevention and treatment.
Related Concept Videos
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...